Innovative Molecules GmbH
1 clinical trials · Sponsor
◉ Watch Innovative Molecules GmbH
| Record | Firm | Date |
|---|---|---|
| Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of IM-250 in Healthy Volunteers (NCT06435507) | Innovative Molecules GmbH | 2023-04-25 |
Track Innovative Molecules GmbH automatically
Every clearance here is in the API, with alerts when new ones post.